You are viewing archived content

Please note that this page is a static copy of a previously published web page and is no longer actively maintained.
Be aware that the information contained here may be out-of-date.
For the most recent information, we recommend visiting the main website of the European Union Drugs Agency (EUDA).

Table TDI-19. New clients entering outpatient treatment: distribution by primary drug at treatment in 2003 for those countries supplying data

Country

Opiates

Cocaine

Stimulants

Hypnotics sedatives

Hallucinogens

Volatile inhalants

Cannabis

Other substances

Czech Republic

18.5

0.6

35.7

1.8

0.6

3.5

39.0

0.2

Denmark

24.8

5.7

14.1

2.5

0.0

0.0

47.3

5.6

Germany

35.2

7.1

8.9

0.9

0.3

0.1

46.6

0.8

Greece

76.6

1.3

0.7

1.6

0.1

0.3

19.4

0.0

Cyprus

52.2

7.0

7.0

1.7

0.0

0.9

31.3

0.0

Latvia

63.8

1.4

14.2

10.6

0.7

6.4

2.1

0.7

Luxembourg

29.2

16.7

50.0

4.2

 

 

 

 

Hungary

11.8

0.7

10.4

9.2

0.3

1.7

54.6

11.3

Malta

68.9

7.5

1.2

0.0

0.0

0.0

22.0

0.4

Netherlands

15.9

40.9

7.0

2.2

1.0

0.0

32.0

0.9

Slovenia

79.2

1.0

1.2

0.2

0.0

0.2

18.2

0.0

Slovakia

29.3

1.5

31.3

2.2

0.7

4.7

30.0

0.2

Finland

19.3

0.5

32.3

5.9

0.4

0.2

40.4

1.1

Sweden

19.4

1.0

23.9

12.8

0.0

1.2

38.4

3.3

United Kingdom

58.8

12.3

6.1

2.3

0.1

0.7

17.6

2.0

Bulgaria

90.2

1.6

1.3

1.6

0.0

0.6

4.7

0.0

Romania

38.9

2.3

2.3

33.0

0.7

3.6

13.2

5.9

Source:

2004 Reitox national reports - TDI outpatient treatment centres – see [Table TDI-14]

Data filter | tditab19-en.xml